Hospital Avoidance Strategies for Treatment of Acute Bacterial Skin and Skin Structure Infection (ABSSSI)
Latest Information Update: 12 Dec 2022
At a glance
- Drugs Dalbavancin (Primary) ; Antibacterials; Cefazolin; Vancomycin
- Indications Bacterial infections; Gram-positive infections; Skin infections
- Focus Therapeutic Use
- 22 Oct 2021 Status changed from recruiting to discontinued.
- 03 Aug 2020 Planned End Date changed from 4 Jun 2020 to 1 Dec 2021.
- 03 Aug 2020 Planned primary completion date changed from 4 Mar 2020 to 1 Sep 2021.